SKIM names Maura Coracini as Managing Director, Latin America
SKIM has named Maura Coracini as Managing Director, Latin America. Based in the São Paulo area.
In today’s fast-paced digital world, people are connecting, searching, communicating and sharing as never before. In the moment. From dawn to dusk. Time is precious, speed is of the essence and attention spans are short. Yet expectations of market research have never been greater.
To stay relevant, marketing professionals must adjust to the new reality and innovate to attract and engage respondents quickly and in ways that secure more meaningful results.
This presentation at the IIeX Europe 2018 introduced a novel technology developed in response to the new dynamics and recognition that measuring purely rational processes is no longer sufficient.
Insights from why a beer ad could be the start to better healthcare insights
Combining an innovative implicit research technique with an engaging mobile interface, our technology leverages familiar swiping and tapping techniques to give respondents an intuitive user experience that helps connect with their natural behavior. Advanced algorithms then use the recorded choices and reaction times to model outcomes that are more reflective of the instinctual behavior consumers display in the market.
The technology has cross-cultural applicability and scores higher than traditional approaches as fun, interactive and refreshing. Through a case study, you will learn its success within consumer market research where it delivers better results through the capture of both stated and “unstated” behavior, as well as improving respondent engagement.
In anticipation of its exciting potential in healthcare – where the use of mobile devices is now ubiquitous, where a growing need for deeper physician insights is challenged by low and falling survey response rates, and where the patient perspective is moving front and center of decision making – this presentation will stimulate creative thinking to question and explore opportunities to overcome current barriers for pharma market research.
